COVID-19 Vaccine Acceptance Level in Ethiopia: A Systematic Review and Meta-Analysis.

IF 2.6
Addisu Tadesse Sahile, Girma Demissie Gizaw, Tennyson Mgutshini, Zewdu Minwuyelet Gebremariam, Getabalew Endazenaw Bekele
{"title":"COVID-19 Vaccine Acceptance Level in Ethiopia: A Systematic Review and Meta-Analysis.","authors":"Addisu Tadesse Sahile,&nbsp;Girma Demissie Gizaw,&nbsp;Tennyson Mgutshini,&nbsp;Zewdu Minwuyelet Gebremariam,&nbsp;Getabalew Endazenaw Bekele","doi":"10.1155/2022/2313367","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 pandemic has had a devastating impact on the everyday lives of the world's population and to this end, the development of curative vaccines was upheld as a welcome panacea. Despite the undeniable negative impact of the disease on human beings, lower than expected proportions of people have taken up the vaccines, particularly in the developing non-Western world. Ethiopia represents an interesting case example, of a nation where COVID-19 vaccine acceptance levels have not been well investigated and a need exists to assess the overall level of vaccine acceptance.</p><p><strong>Methods: </strong>A systematic multidatabase search for relevant articles was carried out across Google Scholar, Web of Science, Science Direct, Hinari, EMBASE, Boolean operator, and PubMed. Two reviewers independently selected, reviewed, screened, and extracted data by using a Microsoft Excel spreadsheet. The Joanna Briggs Institute prevalence critical appraisal tools and the modified NewcastleOttawa Scale (NOS) were used to assess the quality of evidence. All studies conducted in Ethiopia, reporting vaccine acceptance rates were incorporated. The extracted data were imported into the comprehensive meta-analysis version 3.0 for further analysis. Heterogeneity was confirmed using Higgins's method, and publication bias was checked by using Beggs and Eggers tests. A random-effects meta-analysis model with a 95% confidence interval was computed to estimate the pooled prevalence. Furthermore, subgroup analysis based on the study area and sample size was done. <i>Results and Conclusion</i>. After reviewing 67 sources, 18 articles fulfilled the inclusion criteria and were included in the meta-analysis. The pooled prevalence of COVID-19 vaccine acceptance in Ethiopia was 57.8% (95% CI: 47.2%-67.8%). The level of COVID-19 vaccine acceptance in Ethiopia was at a lower rate than necessary to achieve herd immunity. The highest level of vaccine acceptance rate was reported via online or telephone surveys followed by the southern region of Ethiopia. The lowest vaccine acceptance patterns were reported in Addis Ababa.</p>","PeriodicalId":520793,"journal":{"name":"The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale","volume":" ","pages":"2313367"},"PeriodicalIF":2.6000,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436617/pdf/","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2022/2313367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Background: The coronavirus disease 2019 pandemic has had a devastating impact on the everyday lives of the world's population and to this end, the development of curative vaccines was upheld as a welcome panacea. Despite the undeniable negative impact of the disease on human beings, lower than expected proportions of people have taken up the vaccines, particularly in the developing non-Western world. Ethiopia represents an interesting case example, of a nation where COVID-19 vaccine acceptance levels have not been well investigated and a need exists to assess the overall level of vaccine acceptance.

Methods: A systematic multidatabase search for relevant articles was carried out across Google Scholar, Web of Science, Science Direct, Hinari, EMBASE, Boolean operator, and PubMed. Two reviewers independently selected, reviewed, screened, and extracted data by using a Microsoft Excel spreadsheet. The Joanna Briggs Institute prevalence critical appraisal tools and the modified NewcastleOttawa Scale (NOS) were used to assess the quality of evidence. All studies conducted in Ethiopia, reporting vaccine acceptance rates were incorporated. The extracted data were imported into the comprehensive meta-analysis version 3.0 for further analysis. Heterogeneity was confirmed using Higgins's method, and publication bias was checked by using Beggs and Eggers tests. A random-effects meta-analysis model with a 95% confidence interval was computed to estimate the pooled prevalence. Furthermore, subgroup analysis based on the study area and sample size was done. Results and Conclusion. After reviewing 67 sources, 18 articles fulfilled the inclusion criteria and were included in the meta-analysis. The pooled prevalence of COVID-19 vaccine acceptance in Ethiopia was 57.8% (95% CI: 47.2%-67.8%). The level of COVID-19 vaccine acceptance in Ethiopia was at a lower rate than necessary to achieve herd immunity. The highest level of vaccine acceptance rate was reported via online or telephone surveys followed by the southern region of Ethiopia. The lowest vaccine acceptance patterns were reported in Addis Ababa.

Abstract Image

Abstract Image

Abstract Image

埃塞俄比亚COVID-19疫苗接受水平:系统评价和荟萃分析
背景:2019年冠状病毒病大流行对世界人口的日常生活造成了毁灭性的影响,为此,开发治疗性疫苗被认为是一种受欢迎的灵丹妙药。尽管这种疾病对人类产生了不可否认的负面影响,但接种疫苗的人口比例低于预期,特别是在发展中非西方世界。埃塞俄比亚是一个有趣的例子,该国尚未对COVID-19疫苗接受水平进行充分调查,有必要评估疫苗接受的总体水平。方法:通过Google Scholar、Web of Science、Science Direct、Hinari、EMBASE、Boolean operator和PubMed对相关文章进行系统的多数据库检索。两名审阅者通过使用Microsoft Excel电子表格独立地选择、审阅、筛选和提取数据。采用乔安娜布里格斯研究所流行关键评估工具和改进的纽卡斯尔渥太华量表(NOS)来评估证据的质量。所有在埃塞俄比亚进行的报告疫苗接受率的研究都被纳入其中。将提取的数据导入综合meta分析3.0版本进行进一步分析。异质性采用Higgins方法确认,发表偏倚采用Beggs和Eggers检验。计算随机效应荟萃分析模型,置信区间为95%,以估计合并患病率。并根据研究区域和样本量进行亚组分析。结果与结论。在审查了67个来源后,有18篇文章符合纳入标准,被纳入meta分析。埃塞俄比亚COVID-19疫苗接受率的总流行率为57.8% (95% CI: 47.2%-67.8%)。埃塞俄比亚的COVID-19疫苗接受率低于实现群体免疫所需的水平。通过在线或电话调查报告的疫苗接种率最高,其次是埃塞俄比亚南部地区。据报告,亚的斯亚贝巴的疫苗接受情况最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信